Fig. 4From: Clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinomaThe mutation distribution of the actionable genes in ORI and MSK cohort. a The mutation distribution in BRAF. b The mutation distribution in KRAS. c The mutation distribution in IDH1Back to article page